person · Reporting owner
Douglas Robert Andrew
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GLOBUS MEDICAL INCGMED · Entity 3496 | Director | January 21, 2026 | January 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GLOBUS MEDICAL INC
Report date January 21, 2026 · Filed January 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy Class A Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $94.15 · Expires 2036-01-21 | Direct | 15,000 |
Reported balance
After 2026-01-21 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-01-21 · Grant · Acquired 15,000 · Balance 15,000 F1: These options were granted on January 21, 2026, and will vest on January 1, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: These options were granted on January 21, 2026, and will vest on January 1, 2027.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
RESMED INC
Report date January 02, 2024 · Filed January 03, 2024
Section 16 reporting ended · disclosed 2024-01-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| ResMed Common StockSEC Table I · non-derivative | Direct | 11,080 |
Reported balance
Holding disclosure · report date 2024-01-02 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 11,080 F1: Mr. Douglas is no longer subject to reporting under his new role. |
| ResMed Common StockSEC Table I · non-derivative | IndirectDouglas Family Trust | 253,295 |
Reported balance
Holding disclosure · report date 2024-01-02 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 253,295 |
Filing footnotes · ownership attribution and instrument terms
F1: Mr. Douglas is no longer subject to reporting under his new role.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 17, 2020 Filed Aug 18, 2020 18:24 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,132 | $177.55 | $200,986.60 |
DisclosureSEC source: 0001127602-20-023768 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Indirect · Douglas Family Trust Disclosed balance after: 184,585 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| July 22, 2020 Filed Jul 24, 2020 21:00 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | PurchaseClass A Common Stock | 690 | $47.75 | $32,947.50 |
DisclosureSEC source: 0001209191-20-043617 · doc4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,390 F1 · kind: This purchase was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at a price range of $47.74 to $47.77, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in footnote (2) of this Form 4. Read SEC document |
| July 15, 2020 Filed Jul 17, 2020 15:27 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,026 | $196.98 | $202,101.48 |
DisclosureSEC source: 0001127602-20-021696 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Indirect · Douglas Family Trust Disclosed balance after: 185,717 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| June 22, 2020 Filed Jun 24, 2020 20:20 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | PurchaseClass A Common Stock | 700 | $48.20 | $33,740.00 |
DisclosureSEC source: 0001209191-20-038729 · doc4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 700 F1 · kind: This purchase was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 23:45 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,245 | $158.79 | $197,693.55 |
DisclosureSEC source: 0001127602-20-019805 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Indirect · Douglas Family Trust Disclosed balance after: 186,743 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| May 15, 2020 Filed May 19, 2020 16:55 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,228 | $162.05 | $198,997.40 |
DisclosureSEC source: 0001127602-20-017069 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Indirect · Douglas Family Trust Disclosed balance after: 187,988 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| April 15, 2020 Filed Apr 16, 2020 23:13 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,222 | $159.03 | $194,334.66 |
DisclosureSEC source: 0001127602-20-013950 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Indirect · Douglas Family Trust Disclosed balance after: 189,216 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| March 16, 2020 Filed Mar 17, 2020 21:16 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,336 | $137.49 | $183,686.64 |
DisclosureSEC source: 0001127602-20-011109 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Indirect · Douglas Family Trust Disclosed balance after: 190,438 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| February 18, 2020 Filed Feb 19, 2020 21:10 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,133 | $176.14 | $199,566.62 |
DisclosureSEC source: 0001127602-20-006393 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Indirect · Douglas Family Trust Disclosed balance after: 191,774 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| January 15, 2020 Filed Jan 17, 2020 22:44 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,264 | $158.43 | $200,255.52 |
DisclosureSEC source: 0001127602-20-001950 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Indirect · Douglas Family Trust Disclosed balance after: 150,780 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 20:42 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,302 | $154.71 | $201,432.42 |
DisclosureSEC source: 0001127602-19-035362 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Indirect · Douglas Family Trust Disclosed balance after: 152,044 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| December 11, 2019 Filed Dec 17, 2019 21:42 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 25,000 | $0.00 Strike: $56.89 | $0.00 |
DisclosureSEC source: 0001209191-19-060883 · doc4.xml · derivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Class A Common Stock · 25,000 shares Expires 2029-12-11 F1 · derivative.exercise_date: These options were granted on December 11, 2019, and vest over a four-year period with one-fourth (1/4) of the options vesting on December 11, 2020, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| November 21, 2019 Filed Nov 23, 2019 01:09 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock Options · Derivative | 70,006 | $0.00 Strike: $146.34 | $0.00 |
DisclosureSEC source: 0001127602-19-033622 · form4.xml · derivative · entry 4 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,006 Underlying: ResMed Common Stock · 70,006 shares Expires 2026-11-21 F3 · derivative.exercise_date: Represents date options first become exercisable. Options vest 1/3 annually each November 11, 2020, 2021 and 2022. Read SEC document |
| November 21, 2019 Filed Nov 23, 2019 01:09 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 46,586 | $146.34 | $6,817,395.24 |
DisclosureSEC source: 0001127602-19-033622 · form4.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,671 F2 · kind: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2016. Read SEC document |
| November 21, 2019 Filed Nov 23, 2019 01:09 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 78,648 | $146.34 | $11,509,348.32 |
DisclosureSEC source: 0001127602-19-033622 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,257 F1 · kind: Represents performance-based restricted stock units granted on November 16, 2016. The shares were earned on November 21, 2019, when the compensation committee certified that the performance metrics were met. Read SEC document |
| November 18, 2019 Filed Nov 20, 2019 21:08 UTC | RESMED INC RMD · Entity 2692 | GiftResMed Common Stock | 680 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-033356 · form4.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Indirect · Douglas Family Trust Disclosed balance after: 153,346 F1 · kind: Gift of shares to The Douglas Family Fund, a donor advised charitable fund. Mr. Douglas has no beneficial interest, control or dispositive power over the gifted shares. Read SEC document |
| November 18, 2019 Filed Nov 20, 2019 21:08 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,360 | $146.70 | $199,512.00 |
DisclosureSEC source: 0001127602-19-033356 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Indirect · Douglas Family Trust Disclosed balance after: 154,026 Read SEC document |
| November 11, 2019 Filed Nov 14, 2019 00:12 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 6,365 | $143.88 | $915,796.20 |
DisclosureSEC source: 0001127602-19-032662 · form4.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,476 F3 · kind: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2016. Read SEC document |
| November 11, 2019 Filed Nov 14, 2019 00:12 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 2,416 | $143.88 | $347,614.08 |
DisclosureSEC source: 0001127602-19-032662 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,841 F1 · kind: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2017. F2 · balance_after: Includes 117.14 shares of ResMed stock purchased on October 31, 2019, through the ResMed Employee Stock Purchase Plan. Read SEC document |
| October 24, 2019 Filed Oct 25, 2019 20:22 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 5,726 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-031081 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,140 F1 · shares: Represents performance-based restricted stock units granted on November 14, 2018. The shares were earned on October 24, 2019, when the compensation committee certified that the performance metrics were met for this portion of the grant. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date. Read SEC document |
| October 15, 2019 Filed Oct 16, 2019 21:57 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 3,302 | $0.00 Strike: $43.63 | $0.00 |
DisclosureSEC source: 0001127602-19-030656 · form4.xml · derivative · entry 4 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: ResMed Commmon Stock · 3,302 shares Expires 2020-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| October 15, 2019 Filed Oct 16, 2019 21:57 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 774 | $130.25 | $100,813.50 |
DisclosureSEC source: 0001127602-19-030656 · form4.xml · nonDerivative · entry 3 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Indirect · Douglas Family Trust Disclosed balance after: 147,519 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| October 15, 2019 Filed Oct 16, 2019 21:57 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 3,302 | $130.25 | $430,085.50 |
DisclosureSEC source: 0001127602-19-030656 · form4.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,414 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| October 15, 2019 Filed Oct 16, 2019 21:57 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 3,302 | $43.63 | $144,066.26 |
DisclosureSEC source: 0001127602-19-030656 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,716 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 18:52 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 3,307 | $0.00 Strike: $43.63 | $0.00 |
DisclosureSEC source: 0001127602-19-028561 · form4.xml · derivative · entry 4 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,302 Underlying: ResMed Commmon Stock · 3,307 shares Expires 2020-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 18:52 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 757 | $131.63 | $99,643.91 |
DisclosureSEC source: 0001127602-19-028561 · form4.xml · nonDerivative · entry 3 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Indirect · Douglas Family Trust Disclosed balance after: 148,293 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 18:52 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 3,307 | $131.63 | $435,300.41 |
DisclosureSEC source: 0001127602-19-028561 · form4.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,414 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 18:52 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 3,307 | $43.63 | $144,284.41 |
DisclosureSEC source: 0001127602-19-028561 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,721 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| August 15, 2019 Filed Aug 16, 2019 16:20 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 3,307 | $0.00 Strike: $43.63 | $0.00 |
DisclosureSEC source: 0001127602-19-026838 · form4.xml · derivative · entry 4 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,609 Underlying: ResMed Commmon Stock · 3,307 shares Expires 2020-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| August 15, 2019 Filed Aug 16, 2019 16:20 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 763 | $131.12 | $100,044.56 |
DisclosureSEC source: 0001127602-19-026838 · form4.xml · nonDerivative · entry 3 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Indirect · Douglas Family Trust Disclosed balance after: 149,050 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| August 15, 2019 Filed Aug 16, 2019 16:20 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 3,307 | $131.12 | $433,613.84 |
DisclosureSEC source: 0001127602-19-026838 · form4.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,414 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| August 15, 2019 Filed Aug 16, 2019 16:20 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 3,307 | $43.63 | $144,284.41 |
DisclosureSEC source: 0001127602-19-026838 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,721 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| July 15, 2019 Filed Jul 17, 2019 15:44 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 3,307 | $0.00 Strike: $43.63 | $0.00 |
DisclosureSEC source: 0001127602-19-024715 · form4.xml · derivative · entry 4 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,916 Underlying: ResMed Commmon Stock · 3,307 shares Expires 2020-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| July 15, 2019 Filed Jul 17, 2019 15:44 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 804 | $124.50 | $100,098.00 |
DisclosureSEC source: 0001127602-19-024715 · form4.xml · nonDerivative · entry 3 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Indirect · Douglas Family Trust Disclosed balance after: 149,813 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| July 15, 2019 Filed Jul 17, 2019 15:44 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 3,307 | $124.50 | $411,721.50 |
DisclosureSEC source: 0001127602-19-024715 · form4.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,414 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| July 15, 2019 Filed Jul 17, 2019 15:44 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 3,307 | $43.63 | $144,284.41 |
DisclosureSEC source: 0001127602-19-024715 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,721 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 17:39 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 3,307 | $0.00 Strike: $43.63 | $0.00 |
DisclosureSEC source: 0001127602-19-022170 · form4.xml · derivative · entry 4 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,223 Underlying: ResMed Commmon Stock · 3,307 shares Expires 2020-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 17:39 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 847 | $118.44 | $100,318.68 |
DisclosureSEC source: 0001127602-19-022170 · form4.xml · nonDerivative · entry 3 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Indirect · Douglas Family Trust Disclosed balance after: 150,617 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 17:39 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 3,307 | $118.44 | $391,681.08 |
DisclosureSEC source: 0001127602-19-022170 · form4.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,414 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 17:39 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 3,307 | $43.63 | $144,284.41 |
DisclosureSEC source: 0001127602-19-022170 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,721 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| May 15, 2019 Filed May 16, 2019 16:50 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 3,307 | $0.00 Strike: $43.63 | $0.00 |
DisclosureSEC source: 0001127602-19-018678 · form4.xml · derivative · entry 4 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,530 Underlying: ResMed Commmon Stock · 3,307 shares Expires 2020-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F3 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| May 15, 2019 Filed May 16, 2019 16:50 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 893 | $111.35 | $99,435.55 |
DisclosureSEC source: 0001127602-19-018678 · form4.xml · nonDerivative · entry 3 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Indirect · Douglas Family Trust Disclosed balance after: 151,464 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| May 15, 2019 Filed May 16, 2019 16:50 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 3,307 | $111.35 | $368,234.45 |
DisclosureSEC source: 0001127602-19-018678 · form4.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,414 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| May 15, 2019 Filed May 16, 2019 16:50 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 3,307 | $43.63 | $144,284.41 |
DisclosureSEC source: 0001127602-19-018678 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,721 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · balance_after: Includes 117.072 shares of ResMed stock purchased on April 30, 2019, through the ResMed Employee Stock Purchase Plan. Read SEC document |
| April 15, 2019 Filed Apr 16, 2019 21:55 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 3,307 | $0.00 Strike: $43.63 | $0.00 |
DisclosureSEC source: 0001127602-19-015601 · form4.xml · derivative · entry 4 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,837 Underlying: ResMed Commmon Stock · 3,307 shares Expires 2020-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| April 15, 2019 Filed Apr 16, 2019 21:55 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 978 | $102.29 | $100,039.62 |
DisclosureSEC source: 0001127602-19-015601 · form4.xml · nonDerivative · entry 3 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Indirect · Douglas Family Trust Disclosed balance after: 152,357 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| April 15, 2019 Filed Apr 16, 2019 21:55 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 3,307 | $102.29 | $338,273.03 |
DisclosureSEC source: 0001127602-19-015601 · form4.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,297 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| April 15, 2019 Filed Apr 16, 2019 21:55 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 3,307 | $43.63 | $144,284.41 |
DisclosureSEC source: 0001127602-19-015601 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,604 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| March 15, 2019 Filed Mar 19, 2019 21:31 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 3,307 | $0.00 Strike: $43.63 | $0.00 |
DisclosureSEC source: 0001127602-19-012302 · form4.xml · derivative · entry 4 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,144 Underlying: ResMed Commmon Stock · 3,307 shares Expires 2020-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| March 15, 2019 Filed Mar 19, 2019 21:31 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 991 | $100.90 | $99,991.90 |
DisclosureSEC source: 0001127602-19-012302 · form4.xml · nonDerivative · entry 3 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Indirect · Douglas Family Trust Disclosed balance after: 153,335 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.